Michael F. Powell's most recent trade in Galera Therapeutics Inc was a trade of 64,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Galera Therapeutics Inc | Michael F. Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 64,000 | 64,000 | - | - | Stock Option (Right to Buy) | |
Galera Therapeutics Inc | Michael F. Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Galera Therapeutics Inc | Michael F. Powell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 13,179 | 13,179 | - | - | Stock Option (Right to Buy) | |
Galera Therapeutics Inc | Michael F. Powell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 13,179 | 13,179 | - | - | Stock Option (Right to Buy) |